Skip to main content

Peer Review reports

From: Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells

Original Submission
4 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Mar 2023 Reviewed Reviewer Report
28 Mar 2023 Reviewed Reviewer Report
21 May 2023 Author responded Author comments - Seiichi Okabe
Resubmission - Version 3
21 May 2023 Submitted Manuscript version 3
7 Jun 2023 Author responded Author comments - Seiichi Okabe
Resubmission - Version 4
7 Jun 2023 Submitted Manuscript version 4
21 Jun 2023 Author responded Author comments - Seiichi Okabe
Resubmission - Version 5
21 Jun 2023 Submitted Manuscript version 5
22 Jun 2023 Author responded Author comments - Seiichi Okabe
Resubmission - Version 6
22 Jun 2023 Submitted Manuscript version 6
10 Jul 2023 Reviewed Reviewer Report
11 Jul 2023 Reviewed Reviewer Report
25 Jul 2023 Author responded Author comments - Seiichi Okabe
Resubmission - Version 7
25 Jul 2023 Submitted Manuscript version 7
12 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
16 Aug 2023 Editorially accepted
5 Sep 2023 Article published 10.1186/s12885-023-11304-4

You can find further information about peer review here.

Back to article page